Guide

How to Read a COA (Certificate of Analysis)

A Certificate of Analysis (COA) is the primary document a peptide supplier uses to demonstrate that a specific batch of product meets stated quality specifications. For anyone evaluating research-use-only (RUO) peptide suppliers, the COA is the single most important piece of documentation to review. This guide explains what a COA is, how to read its key sections, what HPLC and mass spectrometry results mean, what purity levels are typical for research purposes, and how to distinguish a genuine COA from a marketing document.

Overview

What a COA Is and Why It Matters

A Certificate of Analysis is a lab-generated document that reports the measured properties of a specific production batch of a substance. For peptides, a COA typically confirms the compound's identity, purity, and molecular mass. A legitimate COA is tied to a specific batch or lot number, references the analytical methods used, and is generated by a qualified laboratory — either the supplier's own analytical team or, ideally, an independent third-party lab. The COA is the primary evidence a supplier uses to substantiate claims about what is in the vial. Without a COA, there is no documented basis for trusting that a peptide product matches its label.

Key points

• A COA is batch-specific — it reports results for one production run, not for all products a supplier sells.
• A COA should identify the product name, batch or lot number, testing date, and the laboratory that performed the analysis.
• COAs are the standard quality documentation in pharmaceutical and chemical manufacturing. Their absence from a peptide supplier is a significant red flag.
• Research-use-only peptide suppliers are not regulated as drug manufacturers, so COA quality and completeness vary widely across the market.
• A COA is not a guarantee of safety or efficacy — it is a documentation of analytical results for a specific batch.

Structure

The Key Sections of a COA

A well-constructed peptide COA contains three essential analytical sections: identity testing, purity testing, and mass verification. Each section addresses a different question: Is the molecule what the label says it is? How much of the sample is the target compound versus impurities? And does the molecular weight match the expected value? Together, these three sections provide complementary evidence about the quality of the batch.

Key points

• Identity testing confirms that the peptide is the correct molecule — typically via mass spectrometry or amino acid analysis.
• Purity testing measures what percentage of the sample is the target peptide versus impurities, degradation products, or residual solvents — typically via HPLC.
• Mass verification confirms the molecular weight of the peptide matches the calculated theoretical mass — typically via mass spectrometry.
• Some COAs include additional sections: net content (weight), appearance, solubility, residual solvent testing, and microbiological testing.
• A COA missing any of the three core sections — identity, purity, or mass — is incomplete and should be treated with skepticism.

Method

HPLC (High-Performance Liquid Chromatography): What It Means and What to Look For

High-Performance Liquid Chromatography (HPLC) is the most common analytical method used to measure peptide purity. HPLC works by passing a dissolved sample through a chromatographic column under high pressure, which separates the components of the mixture based on their chemical properties. The separated components are detected and quantified, producing a chromatogram — a graph showing peaks corresponding to each component. The area under the main peak, relative to the total area of all peaks, gives the reported purity percentage. A single sharp, dominant peak indicates high purity. Multiple smaller peaks suggest impurities, degradation products, or residual solvents.

Key points

• HPLC purity is reported as a percentage — typically the area of the main peak relative to all detected peaks. A result of 99% or higher is common for well-manufactured research peptides.
• The chromatogram should show a single dominant peak. Multiple significant peaks indicate the presence of impurities or degradation products.
• The COA should specify the HPLC method used — including column type, mobile phase, and detection wavelength. A report that simply states 'purity: 99%' without method details is less credible.
• Reverse-phase HPLC (RP-HPLC) is the most common method for peptide purity analysis. The COA should state which method was used.
• Purity percentages below 95% should prompt questions about manufacturing quality, storage conditions, or product age.
• HPLC measures chemical purity, not biological potency. A 99% pure peptide is not necessarily biologically active or effective.

Method

Mass Spectrometry (MS): What It Means and Why It Matters

Mass spectrometry (MS) is an analytical technique that measures the mass-to-charge ratio of molecules in a sample. For peptide COAs, MS serves two purposes: identity confirmation and molecular weight verification. The mass spectrum shows whether the dominant molecular species in the sample has the expected molecular weight for the labeled peptide. If the measured mass matches the calculated theoretical mass, this is strong evidence that the correct peptide is present. If the mass does not match, the sample may be a different compound, a truncated or modified version, or contaminated. MS is the primary method for confirming that a peptide is what the label claims it is.

Key points

• Mass spectrometry confirms the molecular weight of the peptide. The measured mass should match the calculated theoretical mass within a small tolerance (typically within 1 Dalton for small peptides).
• The two most common MS methods for peptide analysis are MALDI-TOF (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight) and ESI (Electrospray Ionization). The COA should specify which was used.
• A mass spectrum showing a single peak at the expected mass is strong evidence of identity. Multiple unexpected peaks may indicate impurities, adducts, or the wrong compound entirely.
• MS confirms identity but does not directly measure purity — that is the role of HPLC. Both tests are needed for a complete quality assessment.
• A COA that reports a purity percentage but does not include mass spectrometry data has not confirmed the identity of the compound. This is a significant gap.

Standards

Purity Percentages and What Is Acceptable for Research Purposes

For research-use-only peptides, HPLC purity is the most commonly cited quality metric. But what purity percentage is acceptable depends on the intended use, the analytical method, and the context. In general, research-grade peptides from reputable suppliers report purities of 95% to 99% or higher. Purities below 90% are typically considered low for research purposes and may compromise experimental results. It is important to understand that a purity percentage is only meaningful in the context of the method used, the sample preparation, and the detection parameters. A high number without method details is less informative than a slightly lower number with full analytical transparency.

Key points

• Purity of 98% or higher is standard for well-manufactured research peptides from reputable suppliers. Many report 99% or higher.
• Purity of 95-98% is acceptable for many research applications but may warrant questions about the impurity profile.
• Purity below 95% is below the typical range for research-grade peptides. Suppliers reporting below this threshold should explain the result.
• Purity below 90% should be considered a potential quality problem and is atypical for peptides sold as research reagents.
• Always check whether the reported purity is by HPLC area percent (the standard for peptides) or by another method. Different methods can produce different numbers.
• A high purity number without method details, chromatogram, or testing date is less meaningful than a slightly lower number with full documentation.

Warning

Red Flags on a COA

Not all COAs are created equal. Some documents that suppliers label as 'Certificates of Analysis' are missing the analytical data, method references, or traceability information that make a COA meaningful. The following are common red flags that indicate a COA may be incomplete, unreliable, or fabricated.

Key points

• Missing analytical methods: A COA that states a purity percentage without specifying the method (HPLC, MS, etc.), column, or detection parameters is incomplete. Method details are essential for evaluating whether the result is credible.
• Vague or generic reports: A document that says 'purity: high' or 'meets specifications' without providing actual numerical results, chromatograms, or spectra is not a real COA.
• No batch or lot number: A COA that is not tied to a specific batch cannot confirm that the document corresponds to the product being evaluated. Batch numbers are the minimum traceability link between a COA and the physical product.
• No testing date: Without a testing date, there is no way to know whether the COA reflects current product quality or results from years ago. Products can degrade over time.
• No laboratory identification: A COA should identify the lab that performed the testing. If the lab is unnamed or if the COA appears to be self-generated by the supplier with no lab reference, credibility is reduced.
• No chromatogram or spectra: While not all COAs include raw data, the absence of any chromatographic or spectral output — especially when combined with other red flags — suggests the results may not be from actual analysis.
• Round-number purities: A COA reporting exactly '99.0%' or '100%' with no decimal variation across all batches may indicate fabricated or templated results rather than genuine analytical measurements.
• Same COA reused for different batches: If a supplier provides the same COA document for different lot numbers, the testing is not batch-specific and the document is not a valid COA.

Critical

The Difference Between a Real COA and a Marketing Document

Some peptide suppliers provide documents that look like COAs but are actually marketing materials. A real COA is an analytical document generated by a laboratory. A marketing document is a promotional sheet that may include quality claims, purity numbers, or even logos that resemble a COA, but lacks the analytical substance that makes a COA meaningful. The distinction matters because a marketing document provides no actual evidence of product quality — it is designed to reassure, not to document.

Key points

• A real COA is generated by a laboratory and includes: product name, batch number, testing date, analytical methods, numerical results, chromatograms or spectra, and laboratory identification.
• A marketing document may include quality claims, purity percentages, or logos but lacks: batch-specific traceability, method details, raw analytical data, or laboratory identification.
• A real COA is unique to a specific batch. A marketing document is often generic and reused across multiple products or batches.
• A real COA may show results that are less than perfect (e.g., 97.2% purity). A marketing document often shows uniformly perfect results across all batches.
• A real COA references specific instruments, columns, solvents, and parameters. A marketing document uses vague language like 'lab-tested' or 'pharmaceutical grade.'
• The FDA has issued warning letters to peptide sellers who make quality claims without adequate documentation. RUO labeling does not exempt sellers from accountability for false or misleading quality statements.

Verification

How to Verify a COA Independently (Third-Party Testing)

The strongest evidence of product quality comes from independent, third-party testing. This means sending a sample of the peptide to an independent analytical laboratory that is not affiliated with the supplier. The independent lab performs its own HPLC, MS, or other analyses and produces its own COA. Comparing the supplier's COA with an independent COA for the same batch is the gold standard for verification. If the results match, it increases confidence in the supplier's documentation. If they diverge significantly, it raises questions about the supplier's testing accuracy or integrity.

Key points

• Independent third-party testing removes the conflict of interest that exists when a supplier tests its own products and reports its own results.
• Independent laboratories specializing in peptide analysis include Janoshik Analytical, Quantum Analytical, and Eurofins. These labs can perform HPLC, MS, and amino acid analysis.
• To verify a COA, obtain a sample from the same batch, send it to an independent lab, and compare the results. Identity, purity, and mass should all match within reasonable analytical tolerance.
• Third-party testing adds cost and time but is the most reliable way to validate supplier claims, especially for research programs where batch quality is critical.
• Community-sourced testing reports (e.g., from forum members who have sent samples to independent labs) can be a useful signal, but they are not a substitute for testing your own batch.
• If a supplier refuses to provide a COA, or if a COA cannot be independently verified, the quality of the product is unconfirmed. This is a significant risk for research that depends on peptide identity and purity.

Related pages